Summary

The global Infectious Disease In Vitro Diagnostic (IVD) market remains a cornerstone of effective disease management and public health response. These diagnostic solutions are essential for detecting infectious agents such as bacteria, viruses, and fungi, enabling timely clinical decisions and improving patient outcomes. With the increasing burden of infectious diseases worldwide, the demand for accurate, rapid, and scalable diagnostic tools continues to grow. Advancements in diagnostic technologies and the rising focus on preventive healthcare are further reinforcing the importance of IVD systems across healthcare settings.

Market Insights

The Infectious Disease In Vitro Diagnostic market is anticipated to reach a value of 25.3 billion in 2026 and is projected to grow to 30.7 billion by 2033, registering a CAGR of 2.80% over the forecast period. The steady growth trajectory highlights the ongoing need for diagnostic testing in both routine healthcare and emergency response scenarios. Increasing investments in healthcare infrastructure, expansion of diagnostic laboratories, and continuous innovation in testing technologies are key factors supporting market growth. Additionally, the shift toward decentralized testing and the adoption of automated diagnostic systems are contributing to improved efficiency and accessibility.

Market Drivers

The rising incidence of infectious diseases such as tuberculosis, HIV, hepatitis, and respiratory infections is a major driver for the IVD market. Frequent outbreaks and the emergence of new pathogens have intensified the demand for reliable diagnostic solutions. Urbanization, population mobility, and changing environmental conditions have also contributed to the spread of infectious diseases, further emphasizing the need for advanced diagnostic capabilities.

Technological progress in molecular diagnostics and immunoassay-based testing has significantly enhanced the accuracy and speed of disease detection. These innovations enable early diagnosis, which is critical for effective treatment and containment of infections. The increasing adoption of point-of-care testing devices is also driving market growth, as they provide rapid results and reduce dependency on centralized laboratories.

Supportive government policies and public health initiatives aimed at controlling infectious diseases are playing a vital role in market expansion. Increased funding for research and development and efforts to strengthen diagnostic infrastructure in emerging economies are creating favorable growth conditions.

Business Opportunity

The market presents substantial opportunities, particularly in developing regions where healthcare systems are undergoing rapid transformation. Expanding access to diagnostic services in rural and remote areas is a key area of growth, especially with the rising adoption of portable and point-of-care diagnostic devices. These solutions offer convenience and efficiency, making them highly suitable for resource-limited settings.

Innovation in diagnostic technologies is opening new avenues for market players. The integration of artificial intelligence and data-driven analytics into diagnostic platforms is enhancing disease detection, monitoring, and predictive capabilities. Companies are also focusing on developing multiplex assays and advanced molecular tests that can detect multiple pathogens simultaneously.

Strategic collaborations between governments, research institutions, and private companies are fostering technological advancements and improving market penetration. The growing emphasis on early detection and preventive healthcare is expected to sustain long-term demand for infectious disease diagnostics.

Region Analysis

North America continues to dominate the Infectious Disease IVD market, supported by advanced healthcare systems, high healthcare spending, and strong research and development capabilities. The presence of leading diagnostic companies and early adoption of innovative technologies further strengthen the region’s market position.

Europe holds a significant share of the market, driven by increasing awareness about infectious diseases and well-established healthcare infrastructure. Government initiatives and investments in diagnostic research are contributing to steady market growth across the region.

Asia Pacific is expected to witness considerable growth during the forecast period. Factors such as large population base, rising healthcare expenditures, and increasing prevalence of infectious diseases are driving demand for diagnostic solutions. Improvements in healthcare infrastructure and growing awareness about early diagnosis are further supporting market expansion in this region.

Latin America and the Middle East & Africa are emerging as promising markets, with gradual improvements in healthcare access and infrastructure. Government efforts to enhance disease surveillance and diagnostic capabilities are expected to drive adoption of IVD technologies in these regions.

Key Players

• QIAGEN

• Becton, Dickinson and Company

• bioMérieux SA

• Hoffmann-La Roche, Ltd.

• Hologic, Inc. (Gen Probe)

• Abbott

• Quidel Corporation

• Siemens Healthineers AG

• Bio-Rad Laboratories, Inc.

• Danaher

• OraSure Technologies, Inc.

Segmentation

By Product Type

• Instruments

• Reagents

• Software and Services

By Technology

• Immunoassay

• Molecular Diagnostics

• Microbiology

• Others

By Application

• MRSA

• Clostridium Difficile

• Respiratory Virus

• TB and Drug-resistant TB

• Gonorrhea

• HPV

• HIV

• Hepatitis C

• Hepatitis B

• COVID-19

• Others

By End User

• Point-of-care

• Central Laboratories

• Others

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• The Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Infectious Disease In Vitro Diagnostic Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Infectious Disease In Vitro Diagnostic Market Outlook, 2020 - 2033
3.1. Global Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
3.1.1. Instruments
3.1.2. Reagents
3.1.3. Software and Services
3.2. Global Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, Value (US$ Bn), 2020-2033
3.2.1. Immunoassay
3.2.2. Molecular Diagnostics
3.2.3. Microbiology
3.2.4. Others
3.3. Global Infectious Disease In Vitro Diagnostic Market Outlook, by Application, Value (US$ Bn), 2020-2033
3.3.1. MRSA
3.3.2. Clostridium Difficile
3.3.3. Respiratory Virus
3.3.4. TB and Drug-resistant TB
3.3.5. Gonorrhea
3.3.6. HPV
3.3.7. HIV
3.3.8. Hepatitis C
3.3.9. Hepatitis B
3.3.10. COVID-19
3.4. Global Infectious Disease In Vitro Diagnostic Market Outlook, by End User, Value (US$ Bn), 2020-2033
3.4.1. Point-of-care
3.4.2. Central Laboratories
3.4.3. Others
3.5. Global Infectious Disease In Vitro Diagnostic Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.5.1. North America
3.5.2. Europe
3.5.3. Asia Pacific
3.5.4. Latin America
3.5.5. Middle East & Africa
4. North America Infectious Disease In Vitro Diagnostic Market Outlook, 2020 - 2033
4.1. North America Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
4.1.1. Instruments
4.1.2. Reagents
4.1.3. Software and Services
4.2. North America Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, Value (US$ Bn), 2020-2033
4.2.1. Immunoassay
4.2.2. Molecular Diagnostics
4.2.3. Microbiology
4.2.4. Others
4.3. North America Infectious Disease In Vitro Diagnostic Market Outlook, by Application, Value (US$ Bn), 2020-2033
4.3.1. MRSA
4.3.2. Clostridium Difficile
4.3.3. Respiratory Virus
4.3.4. TB and Drug-resistant TB
4.3.5. Gonorrhea
4.3.6. HPV
4.3.7. HIV
4.3.8. Hepatitis C
4.3.9. Hepatitis B
4.3.10. COVID-19
4.4. North America Infectious Disease In Vitro Diagnostic Market Outlook, by End User, Value (US$ Bn), 2020-2033
4.4.1. Point-of-care
4.4.2. Central Laboratories
4.4.3. Others
4.5. North America Infectious Disease In Vitro Diagnostic Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.5.1. U.S. Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
4.5.2. U.S. Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
4.5.3. U.S. Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
4.5.4. U.S. Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
4.5.5. Canada Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
4.5.6. Canada Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
4.5.7. Canada Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
4.5.8. Canada Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Infectious Disease In Vitro Diagnostic Market Outlook, 2020 - 2033
5.1. Europe Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
5.1.1. Instruments
5.1.2. Reagents
5.1.3. Software and Services
5.2. Europe Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, Value (US$ Bn), 2020-2033
5.2.1. Immunoassay
5.2.2. Molecular Diagnostics
5.2.3. Microbiology
5.2.4. Others
5.3. Europe Infectious Disease In Vitro Diagnostic Market Outlook, by Application, Value (US$ Bn), 2020-2033
5.3.1. MRSA
5.3.2. Clostridium Difficile
5.3.3. Respiratory Virus
5.3.4. TB and Drug-resistant TB
5.3.5. Gonorrhea
5.3.6. HPV
5.3.7. HIV
5.3.8. Hepatitis C
5.3.9. Hepatitis B
5.3.10. COVID-19
5.4. Europe Infectious Disease In Vitro Diagnostic Market Outlook, by End User, Value (US$ Bn), 2020-2033
5.4.1. Point-of-care
5.4.2. Central Laboratories
5.4.3. Others
5.5. Europe Infectious Disease In Vitro Diagnostic Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.5.1. Germany Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
5.5.2. Germany Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
5.5.3. Germany Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
5.5.4. Germany Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
5.5.5. Italy Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
5.5.6. Italy Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
5.5.7. Italy Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
5.5.8. Italy Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
5.5.9. France Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
5.5.10. France Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
5.5.11. France Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
5.5.12. France Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
5.5.13. U.K. Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
5.5.14. U.K. Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
5.5.15. U.K. Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
5.5.16. U.K. Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
5.5.17. Spain Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
5.5.18. Spain Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
5.5.19. Spain Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
5.5.20. Spain Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
5.5.21. Russia Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
5.5.22. Russia Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
5.5.23. Russia Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
5.5.24. Russia Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
5.5.25. Rest of Europe Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
5.5.26. Rest of Europe Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
5.5.27. Rest of Europe Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
5.5.28. Rest of Europe Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Infectious Disease In Vitro Diagnostic Market Outlook, 2020 - 2033
6.1. Asia Pacific Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
6.1.1. Instruments
6.1.2. Reagents
6.1.3. Software and Services
6.2. Asia Pacific Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, Value (US$ Bn), 2020-2033
6.2.1. Immunoassay
6.2.2. Molecular Diagnostics
6.2.3. Microbiology
6.2.4. Others
6.3. Asia Pacific Infectious Disease In Vitro Diagnostic Market Outlook, by Application, Value (US$ Bn), 2020-2033
6.3.1. MRSA
6.3.2. Clostridium Difficile
6.3.3. Respiratory Virus
6.3.4. TB and Drug-resistant TB
6.3.5. Gonorrhea
6.3.6. HPV
6.3.7. HIV
6.3.8. Hepatitis C
6.3.9. Hepatitis B
6.3.10. COVID-19
6.4. Asia Pacific Infectious Disease In Vitro Diagnostic Market Outlook, by End User, Value (US$ Bn), 2020-2033
6.4.1. Point-of-care
6.4.2. Central Laboratories
6.4.3. Others
6.5. Asia Pacific Infectious Disease In Vitro Diagnostic Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.5.1. China Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
6.5.2. China Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
6.5.3. China Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
6.5.4. China Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
6.5.5. Japan Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
6.5.6. Japan Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
6.5.7. Japan Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
6.5.8. Japan Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
6.5.9. South Korea Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
6.5.10. South Korea Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
6.5.11. South Korea Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
6.5.12. South Korea Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
6.5.13. India Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
6.5.14. India Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
6.5.15. India Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
6.5.16. India Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
6.5.17. Southeast Asia Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
6.5.18. Southeast Asia Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
6.5.19. Southeast Asia Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
6.5.20. Southeast Asia Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
6.5.21. Rest of SAO Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
6.5.22. Rest of SAO Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
6.5.23. Rest of SAO Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
6.5.24. Rest of SAO Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Infectious Disease In Vitro Diagnostic Market Outlook, 2020 - 2033
7.1. Latin America Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
7.1.1. Instruments
7.1.2. Reagents
7.1.3. Software and Services
7.2. Latin America Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, Value (US$ Bn), 2020-2033
7.2.1. Immunoassay
7.2.2. Molecular Diagnostics
7.2.3. Microbiology
7.2.4. Others
7.3. Latin America Infectious Disease In Vitro Diagnostic Market Outlook, by Application, Value (US$ Bn), 2020-2033
7.3.1. MRSA
7.3.2. Clostridium Difficile
7.3.3. Respiratory Virus
7.3.4. TB and Drug-resistant TB
7.3.5. Gonorrhea
7.3.6. HPV
7.3.7. HIV
7.3.8. Hepatitis C
7.3.9. Hepatitis B
7.3.10. COVID-19
7.4. Latin America Infectious Disease In Vitro Diagnostic Market Outlook, by End User, Value (US$ Bn), 2020-2033
7.4.1. Point-of-care
7.4.2. Central Laboratories
7.4.3. Others
7.5. Latin America Infectious Disease In Vitro Diagnostic Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.5.1. Brazil Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
7.5.2. Brazil Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
7.5.3. Brazil Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
7.5.4. Brazil Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
7.5.5. Mexico Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
7.5.6. Mexico Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
7.5.7. Mexico Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
7.5.8. Mexico Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
7.5.9. Argentina Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
7.5.10. Argentina Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
7.5.11. Argentina Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
7.5.12. Argentina Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
7.5.13. Rest of LATAM Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
7.5.14. Rest of LATAM Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
7.5.15. Rest of LATAM Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
7.5.16. Rest of LATAM Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Infectious Disease In Vitro Diagnostic Market Outlook, 2020 - 2033
8.1. Middle East & Africa Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
8.1.1. Instruments
8.1.2. Reagents
8.1.3. Software and Services
8.2. Middle East & Africa Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, Value (US$ Bn), 2020-2033
8.2.1. Immunoassay
8.2.2. Molecular Diagnostics
8.2.3. Microbiology
8.2.4. Others
8.3. Middle East & Africa Infectious Disease In Vitro Diagnostic Market Outlook, by Application, Value (US$ Bn), 2020-2033
8.3.1. MRSA
8.3.2. Clostridium Difficile
8.3.3. Respiratory Virus
8.3.4. TB and Drug-resistant TB
8.3.5. Gonorrhea
8.3.6. HPV
8.3.7. HIV
8.3.8. Hepatitis C
8.3.9. Hepatitis B
8.3.10. COVID-19
8.4. Middle East & Africa Infectious Disease In Vitro Diagnostic Market Outlook, by End User, Value (US$ Bn), 2020-2033
8.4.1. Point-of-care
8.4.2. Central Laboratories
8.4.3. Others
8.5. Middle East & Africa Infectious Disease In Vitro Diagnostic Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.5.1. GCC Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
8.5.2. GCC Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
8.5.3. GCC Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
8.5.4. GCC Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
8.5.5. South Africa Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
8.5.6. South Africa Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
8.5.7. South Africa Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
8.5.8. South Africa Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
8.5.9. Egypt Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
8.5.10. Egypt Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
8.5.11. Egypt Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
8.5.12. Egypt Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
8.5.13. Nigeria Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
8.5.14. Nigeria Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
8.5.15. Nigeria Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
8.5.16. Nigeria Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
8.5.17. Rest of Middle East Infectious Disease In Vitro Diagnostic Market Outlook, by Product Type, 2020-2033
8.5.18. Rest of Middle East Infectious Disease In Vitro Diagnostic Market Outlook, by Technology, 2020-2033
8.5.19. Rest of Middle East Infectious Disease In Vitro Diagnostic Market Outlook, by Application, 2020-2033
8.5.20. Rest of Middle East Infectious Disease In Vitro Diagnostic Market Outlook, by End User, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. QIAGEN
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Becton, Dickinson and Company
9.4.3. bioMérieux SA
9.4.4. Hoffmann-La Roche, Ltd.
9.4.5. Hologic, Inc. (Gen Probe)
9.4.6. Abbott
9.4.7. Quidel Corporation
9.4.8. Siemens Healthineers AG
9.4.9. Bio-Rad Laboratories, Inc.
9.4.10. Danaher
9.4.11. OraSure Technologies, Inc.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations